Cargando…
The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis
Pre-exposure prophylaxis (PrEP) is considered one of the five “pillars” by UNAIDS to reduce HIV transmission. Moreover, it is a tool for female self-protection against HIV, making it highly relevant to sub-Saharan regions, where women have the highest infection burden. To date, Truvada is the only m...
Autores principales: | Duwal, Sulav, Seeler, Daniel, Dickinson, Laura, Khoo, Saye, von Kleist, Max |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424904/ https://www.ncbi.nlm.nih.gov/pubmed/30918485 http://dx.doi.org/10.3389/fphar.2019.00199 |
Ejemplares similares
-
Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis
por: Duwal, Sulav, et al.
Publicado: (2019) -
Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes
por: Duwal, Sulav, et al.
Publicado: (2018) -
Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection
por: Duwal, Sulav, et al.
Publicado: (2012) -
Correction: Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection
por: Duwal, Sulav, et al.
Publicado: (2012) -
Optimal Treatment Strategies in the Context of ‘Treatment for Prevention’ against HIV-1 in Resource-Poor Settings
por: Duwal, Sulav, et al.
Publicado: (2015)